Abstract
Rezumat

SASO (sindrom de apnee în somn forma obstructivă) este cel mai frecvent tip de apnee în somn, caracterizat de obstruc ia căilor respiratorii superioare în timpul somnului, determinând absen a sau reducerea fluxului aerian, deși există activitatea musculaturii respiratorii. Aceasta contribuie la apari ia multiplelor complica ii, cum ar fi hipertensiunea arterială, obezitatea, diabetul zaharat, patologia cardiacă și cerebrală, afectarea metabolică.
Obiectivul acestui studiu a fost evaluarea comorbidită ilor majore asociate SASO la un grup de 101 de pacien i diagnostica i clinic și polisomnografic cu SASO în cadrul Institutului Marius Nasta din București în perioada 2014-2015. Rezultatele ob inute au eviden iat prevalen a foarte ridicată a afec iunilor ORL, a hipertensiunii arteriale, a dislipidemiei și a refluxului gastroesofagian. De asemenea, în rândul acestor pacien i a fost semnalată existen a crescută a tulburărilor de ritm, (17,8%), precum BRD, ESSV, FiA, dar și a bolii cardiace ischemice (16,83%).
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OSAS arises from the presence of more than one etiologic factor, the most important factor being the reduction in size of the a i r w a y s , w h i c h o c c u r s t h ro u g h t h e hypertrophy of the tonsils, the tongue and the nasal turbinates, by the existence of nasal septum deviation, elongated uvula, chronic rhinitis , as well as adipose tissue (3) deposit in the neck and abdomen. 
During sleep, the activity of the airway dilator muscles decreases, leading to their collapse . In addition, the existence of (6) c r a n i o -f a c i a l a n o m a l i e s d e t e rm i n e d additional reduction in the activity of the genioglossus muscle, thus increasing the risk of OSAS. At the beginning of the apnoea episode, the phasic contraction of the airway dilator muscles is minimal, requiring additional contraction of these muscles to prevent airway collapse . The micro-
awakenings, which define the end of the apnoea episode, increase the dilator muscle tone in the neck, thus restoring upper airway permeability and ventilation . with the thickening of the mandible (11, 12, 13) elements that contribute to the increased risk of OSAS occurrence.
I n a c r o m e g a l y a n d u n t r e a t e d 
Last but not least, we should mention the frequency of psychiatric illnesses, such as depression, anxiety, bipolar disorder frequently manifested in OSAS , slight (15) depression being diagnosed in a high percentage, 62% of women with OSAS, and in men in a percentage of 39% . OSAS is a risk factor for the occurrence and progression of HBP, more than 50% of patients affected by OSAS being diagnosed with hypertension . The presence of OSAS (17, 18) has to be suspected in every patient presenting treatment-resistant HBP, as well as to individuals exceeding by 120% their ideal weight . Treatment-resistant HBP is (19) defined by the persistence of blood pressure i n c re a s e o v e r 1 4 0 / 9 0 m m H g d u r i n g treatment with three antihypertensives used in maximum dose , OSAS being diagnosed (20) in 83% of patients presenting resistant HBP. revealed that the incidence of hypertension is increased in proportion to the severity of O S A S , a l o n g w i t h t h e f a c t t h a t t h e therapeutic effectiveness of HBP is better in patients with slight and medium OSAS . (22) Between OSAS and strokes, there is a close relationship, OSAS being described as a risk factor for the occurrence of strokes, and if the patient also experiences rhythm disorders, such as atrial fibrillation, then the risk of the patient to suffer a stroke is much higher , (23) OSAS being described at 77% of men, i.e.
64% of women with stroke . This is possible (24) because in OSAS cerebral blood flow is reduced . The repeated episodes of (26) develop OSAS is increased in the first 24 hours after the stroke, when adopting the supine position, the patient presents the upper airway collapse , this risk being (27) maintained high also 1 year after the stroke , describing a direct relationship (28, 29) between the severity of these two disorders.
In OSAS, more than 50% of patients exhibit cardiac arrhythmias during sleep, the most common being atrial fibrillation, ventricular tachycardia, type 2 atrioventricular block, premature ventricular contractions ,
describing a direct proportional relationship b e t w e e n t h e s e v e r i t y o f O S A S a n d occurrence of these arrhythmias. These arrhythmias occur due to hypoxemia, hypercapnia, acute atrial dilation, negative intrathoracic pressure, causing progressive damage in the filling of the left ventricle . (30) During sleep, the airway obstruction will increase the oxygen demand of myocardium d u r i n g t h e a p n o e a e p i s o d e a n d , i n conjunction with the degree of hypoxemia, it will lead to the occurrence of myocardial ischaemia due to the occurrence of negative intrathoracic pressure, thus increasing the transmural gradient in the ventricle. The occurrence of myocardial ischaemia in OSAS i s a l s o ex p l a i n e d b y i n c re a s i n g t h e sympathetic activity, which, along with hypoxemia and hypercapnia, will cause an increase in blood pressure and heart rate , (21) thus explaining the high percentage of OSAS in patients with 65.7% IMA . The OSAS (31) treatment has a high clinical importance, specifically the use of PAP, with a lesser degree of recurrence of arterial fibrilation, being 42% in patients who use PAP, compared to 82% in patients with OSAS, but who do not use PAP . (30) Last but not least OSAS determines increases in the risk of sudden death especially during sleep, the risk being higher as the degree of severity of OSAS is higher , this being due to (32) increased sympathetic activity, to increased blood pressure, along with hypoxemia and hypercapnia occurred during the apnoea episode . (33) For the patients diagnosed with severe OSAS, 1 in 3 patients present nocturnal angina pectoris and ST-segment depression, clinical trials showing an improvement in patients who follow treatment with PAP . (17) Also, studies highlighted high prevalence of about 10% for pulmonary hypertension among patients with OSAS, treatment with PAP relieving pulmonary artery pressure having a very important role . (17) Clinical trials demonstrated the high frequency of metabolic disorders, such as dyslipidemia, insulin resistance, low glucose tolerance and type 2 diabetes mellitus (34) among patients with OSAS, and the positive effect of treatment with PAP, emphasising once again the need for prompt and Figure . 4 Prevalence of comorbidities in OSAS in the study batch
